Graham Capital Management, L.P. Pacific Biosciences Of California, Inc. Transaction History

Graham Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.02 - $10.43 $542,145 - $1.41 Million	134,862 New	134,862 $596,000
Q1 2022 May 16, 2022	SELL	$8.43 - $20.9 $138,884 - $344,327	-16,475 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$19.26 - $30.08 $288,900 - $451,200	-15,000 Reduced 47.66%	16,475 $337,000
Q3 2021 Nov 15, 2021	SELL	$24.86 - $35.02 $209,296 - $294,833	-8,419 Reduced 21.1%	31,475 $804,000
Q2 2021 Aug 16, 2021	SELL	$22.3 - $36.02 $111,098 - $179,451	-4,982 Reduced 11.1%	39,894 $1.4 Million
Q1 2021 May 17, 2021	BUY	$26.38 - $51.15 $1.18 Million - $2.3 Million	44,876 New	44,876 $1.49 Million

255

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $450M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.